Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Journal of Cancer|January 4, 2021
Current Ovarian Cancer Maintenance Strategies and Promising New DevelopmentsVinaya Gogineni, Susan Morand, Hannah Staats, et al.
Polish Archives of Internal Medicine|September 15, 2017
Real‑life experience with bortezomib‑based regimens in elderly patients with newly diagnosed multiple myeloma and comorbidities: a Polish retrospective multicenter studyIwona Hus, Adam Walter-Croneck, Anna Masternak, et al.
Gynecologic Oncology|March 15, 2021
Gemogenovatucel-T (Vigil) immunotherapy demonstrates clinical benefit in homologous recombination proficient (HRP) ovarian cancerRodney P Rocconi, Bradley J Monk, Adam Walter, et al.
Scientific Reports|July 5, 2024
3D engineered scaffold for large-scale Vigil immunotherapy productionFabienne Kerneis, Ernest Bognar, Laura Stanbery, et al.
Gynecologic Oncology|October 27, 2021
Gemogenovatucel-T (Vigil) maintenance immunotherapy: 3-year survival benefit in homologous recombination proficient (HRP) ovarian cancerAdam Walter, Rodney P Rocconi, Bradley J Monk, et al.
JCO Precision Oncology|January 14, 2026
Gemogenovatucel-T Advantage in Clonal Tumor Mutation Burden-High Ovarian CancerRobert L Coleman, Rodney Rocconi, Bradley J Monk, et al.
Future Oncology (London, England)|August 5, 2024
Gemogenovatucel-T (Vigil): bi-shRNA plasmid-based targeted immunotherapyJohn Nemunaitis, Laura Stanbery, Adam Walter, et al.
Advanced Functional Materials|May 25, 2026
Synthetic Strategy for mRNA Encapsulation and Gene Delivery with Nanoscale Metal-Organic FrameworksHarrison Douglas Lawson, Huy Hoang Nguyen, Keng-Jung Lee, et al.
Cells|March 6, 2021
Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple MyelomaJoanna Bartosińska, Joanna Purkot, Agnieszka Karczmarczyk, et al.
Journal of Clinical Medicine|February 25, 2023
A Stepwise Screening Protocol for Multiple MyelomaMarta Morawska, Jadwiga Dwilewicz-Trojaczek, Tomasz Stompór, et al.
Pageof 6